Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$62.17 - $97.62 $10,009 - $15,716
161 Added 4.18%
4,016 $393,000
Q4 2022

Feb 14, 2023

BUY
$60.21 - $77.74 $6,984 - $9,017
116 Added 3.1%
3,855 $240,000
Q3 2022

Nov 14, 2022

BUY
$72.92 - $99.73 $44,335 - $60,635
608 Added 19.42%
3,739 $273,000
Q2 2022

Aug 15, 2022

BUY
$84.23 - $147.57 $4,548 - $7,968
54 Added 1.75%
3,131 $296,000
Q1 2022

May 16, 2022

BUY
$122.89 - $171.74 $26,421 - $36,924
215 Added 7.51%
3,077 $425,000
Q4 2021

Feb 14, 2022

SELL
$156.0 - $265.78 $25,740 - $43,853
-165 Reduced 5.45%
2,862 $522,000
Q3 2021

Nov 15, 2021

BUY
$228.69 - $274.2 $5,945 - $7,129
26 Added 0.87%
3,027 $783,000
Q2 2021

Aug 16, 2021

SELL
$169.89 - $231.37 $62,349 - $84,912
-367 Reduced 10.9%
3,001 $689,000
Q1 2021

May 17, 2021

SELL
$143.93 - $207.3 $57,859 - $83,334
-402 Reduced 10.66%
3,368 $567,000
Q4 2020

Feb 16, 2021

BUY
$96.1 - $151.18 $362,297 - $569,948
3,770 New
3,770 $549,000

Others Institutions Holding HSKA

About HESKA CORP


  • Ticker HSKA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 10,818,900
  • Description
  • Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and ...
More about HSKA
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.